TEPP

Across TCGA pan-cancer cohorts, TEPP Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated TEPP data layer compared with 21 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TEPP Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TEPP expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, ESCA, and BRCA are the cancer types where TEPP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.122	0.696	<.001	45	view →
ESCA	OS	Median	II,III,IV	0.124	0.703	<.001	30	view →
BRCA	OS	Median	All	0.750	0.963	.017	8	view →
UCEC	DFS	Median	All	1.000	0.624	.027	6	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

TEPP–HNSC (DFS)

Open the HNSC breakdown →